Trial search - ClinicalTrials.eu

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

Study on Selpercatinib for Adults with Advanced or Metastatic Solid Tumors with RET Activation

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- Selpercatinib
Study Comparing ARV-471 and Palbociclib with Letrozole and Palbociclib for Patients with Estrogen Receptor Positive, HER2-Negative Advanced Breast Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
- (3S)-3-[6-[4-[[1-[4-[(1R,2S)-6-Hydroxy-2-Phenyl-1,2,3,4-Tetrahydronaphthalen-1-Yl]Phenyl]Piperidin-4-Yl]Methyl]Piperazin-1-Yl]-3-Oxo-1H-Isoindol-2-Yl]Piperidine-2,6-Dione
- Palbociclib
Study on the Effects of Samuraciclib and Elacestrant for Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer

Not recruiting

1 1 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
- Samuraciclib
- Elacestrant
Study of Fulvestrant and Samuraciclib for Patients with Advanced HR Positive, HER2-Negative Breast Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Breast cancer metastatic
- Breast cancer
Investigated Drugs:
- Samuraciclib
- Fulvestrant
Study of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer

Not recruiting

3 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
+7
Study of Trastuzumab Deruxtecan for Patients with Unresectable or Metastatic HER2-low or HER2 IHC0 Breast Cancer

Not recruiting

2 1 1
Investigated Drugs:
- Trastuzumab Deruxtecan
Study on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy

Not recruiting

3 1 1 1
Investigated Drugs:
+7
Study on Gallium (68Ga) Tezatabep Matraxetan PET for Evaluating HER2 Status in Patients with Gastro-Esophageal and HER2-Low Breast Cancer

Not recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Gallium (68Ga) Tezatabep Matraxetan
Study on Ribociclib with Hormone Therapy and Radiotherapy for Elderly Patients with Newly Diagnosed Breast Cancer with Positive Hormone Receptors and Negative HER2 Status

Not recruiting

1 1 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
- Ribociclib
Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Not recruiting

3 1 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
- (3S)-3-[6-[4-[[1-[4-[(1R,2S)-6-Hydroxy-2-Phenyl-1,2,3,4-Tetrahydronaphthalen-1-Yl]Phenyl]Piperidin-4-Yl]Methyl]Piperazin-1-Yl]-3-Oxo-1H-Isoindol-2-Yl]Piperidine-2,6-Dione
- Fulvestrant
+9

Opportunities for Healthy Volunteers

Matched clinical trials

We use cookies